Multiple sclerosis trials recruiting in Pennsylvania

All Multiple sclerosis trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
  NCT06587828 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Harrisburg
• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
  NCT06433752 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Bethlehem
• A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
  NCT06782490 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
  NCT06063850 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh
• AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
  NCT06665165 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
  NCT04047628 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Central Vein Sign in Multiple Sclerosis Extension Study
  NCT07424027 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Genes and Environment in Multiple Sclerosis
  NCT01353547 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
  NCT05285891 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
  NCT02994121 · Phase: Not specified · Ages: 7 Years and older · Sex: All (male and female) · Pennsylvania: Pittsburgh
• RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
  NCT07002034 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Study of COYA 302 for the Treatment of ALS
  NCT07161999 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• TSC Biosample Repository and Natural History Database
  NCT05676099 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Pennsylvania: Philadelphia
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh